PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Where we at?, page-386

  1. 614 Posts.
    lightbulb Created with Sketch. 258
    I particularly like this synthesis, this closing remark, from the portfolio manager, that blames the current all time low in share price and low in NAV for his clients, to "current unknowns and equity softness to towards biotech".

    I mean, wow!

    https://hotcopper.com.au/data/attachments/6116/6116834-f16e3a7240834e72befd22eb6438f43b.jpg

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.